LUCENT maximises the chance of success of a potential new medicine in Clinical Development by creating commercially and clinically optimised TPPs, designing pragmatic Clinical Development Plans (CDPs) and study designs, and leading the operationalisation of clinical study programmes.
We do this for biopharma leaders advancing innovative medicines to maximise the chance of success in late-phase clinical development and optimise a new medicines commercial potential at launch.
Medical is our passion, and our work stays true to that. We are made up of industry insiders with a lifetime of experience in new medicine development, who carry a deep understanding of what it takes to succeed in Clinical Development.
We develop detailed, commercially valuable TPPs and provide ongoing strategic clinical guidance rooted in detailed situational analysis and competitive environment insights to maximise the value of potential new medicines in the future marketplace.
We develop comprehensive Clinical Development Plans, including scenario-planning and risk management to maximise the chance of success in clinical development and optimise an asset's commercial potential at launch.
We execute study programmes safely, efficiently and effectively by developing pragmatic Phase 2b & 3 study protocols, managing study set-up and operationalisation, monitoring, data-analysing and CSR writing for sponsors.
We provide collaborative integrated Clinical Development experts who can join your team at any stage of development and deliver immediate impact without the burden of recruitment.
We understand the risks you take on when developing a new compound; the costs, lengthy timelines, plus the regulatory and commercial pressures. With our first-hand experience of Clinical Development, we understand the precision, insight and deep understanding required in this complex landscape.
Phases 2 and 3 are pivotal, where scientific innovation meets real-world application, ensuring that promising treatments move from the laboratory to the hands of those patients who need them most, as swiftly as possible. Biopharma organisations rely on LUCENT's expertise to help streamline the transition from the lab to the real world.
Explore the insights and strategic thinking that have helped bring innovative medicines closer to the patients who need them most.
Insights >Explore the insights and strategic thinking that have helped bring innovative medicines closer to the patients who need them most.
INSIGHTS >
